Shenzhen Salubris Pharmaceuticals Co Ltd (002294) — Free Cash Flow Generation Index
Shenzhen Salubris Pharmaceuticals Co Ltd (002294) has a Free Cash Flow Generation Index of 0.27x as of September 2025. Free cash flow of CN¥108.45 Million represents 0% of operating cash flow (CN¥400.70 Million). See 002294 working capital ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Shenzhen Salubris Pharmaceuticals Co Ltd Free Cash Flow Generation Index (2006–2024)
Historical FCF Generation Index trend for Shenzhen Salubris Pharmaceuticals Co Ltd across 19 annual periods. Explore 002294 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Shenzhen Salubris Pharmaceuticals Co Ltd (2006–2024)
Year-by-year Free Cash Flow Generation Index for Shenzhen Salubris Pharmaceuticals Co Ltd. For the full company profile including market capitalisation, see market value of Shenzhen Salubris Pharmaceuticals Co Ltd.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.47x | CN¥561.45 Million | CN¥1.19 Billion | CN¥624.81 Million | ▲ +144.4% |
| 2023 | 0.19x | CN¥168.44 Million | CN¥869.79 Million | CN¥671.00 Million | ▼ -49.4% |
| 2022 | 0.38x | CN¥371.84 Million | CN¥970.80 Million | CN¥598.96 Million | ▼ -35.4% |
| 2021 | 0.59x | CN¥702.48 Million | CN¥1.18 Billion | CN¥482.50 Million | ▲ +11.3% |
| 2020 | 0.53x | CN¥731.86 Million | CN¥1.37 Billion | CN¥642.47 Million | ▼ -23.5% |
| 2019 | 0.70x | CN¥1.05 Billion | CN¥1.51 Billion | CN¥457.19 Million | ▼ -7.3% |
| 2018 | 0.75x | CN¥1.01 Billion | CN¥1.34 Billion | CN¥332.87 Million | ▼ -2.7% |
| 2017 | 0.77x | CN¥1.13 Billion | CN¥1.46 Billion | CN¥331.67 Million | ▼ -6.8% |
| 2016 | 0.83x | CN¥1.19 Billion | CN¥1.43 Billion | CN¥245.06 Million | ▲ +6.7% |
| 2015 | 0.78x | CN¥820.46 Million | CN¥1.06 Billion | CN¥235.57 Million | ▼ -2.4% |
| 2014 | 0.80x | CN¥781.59 Million | CN¥982.25 Million | CN¥200.65 Million | ▲ +120.4% |
| 2013 | 0.36x | CN¥241.32 Million | CN¥668.52 Million | CN¥427.20 Million | ▼ -19.8% |
| 2012 | 0.45x | CN¥234.46 Million | CN¥521.21 Million | CN¥286.75 Million | ▲ +521.2% |
| 2011 | 0.07x | CN¥19.72 Million | CN¥272.32 Million | CN¥252.60 Million | ▲ +136.7% |
| 2010 | -0.20x | CN¥-36.83 Million | CN¥186.65 Million | CN¥223.48 Million | ▼ -1799.6% |
| 2009 | -0.01x | CN¥-1.39 Million | CN¥134.28 Million | CN¥135.68 Million | ▼ -104.9% |
| 2008 | 0.21x | CN¥16.41 Million | CN¥77.89 Million | CN¥61.48 Million | ▼ -71.5% |
| 2007 | 0.74x | CN¥39.05 Million | CN¥52.75 Million | CN¥13.71 Million | ▲ +286.5% |
| 2006 | 0.19x | CN¥2.30 Million | CN¥12.00 Million | CN¥9.71 Million | — |